Assessment of In vitro Antibacterial Activity and Cytotoxicity Effect of Nigella sativa Oil
dc.contributor.author | Ugur, Ayse Ruveyda | |
dc.contributor.author | Dagi, Hatice Turk | |
dc.contributor.author | Ozturk, Bahadir | |
dc.contributor.author | Tekin, Gulsum | |
dc.contributor.author | Findik, Duygu | |
dc.date.accessioned | 2020-03-26T19:23:08Z | |
dc.date.available | 2020-03-26T19:23:08Z | |
dc.date.issued | 2016 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Background: Methicillin resistance is a serious health concern since it has spread among Staphylococcus aureus and coagulase-negative Staphylococci (CoNS) that are frequent community and nosocomial pathogens worldwide. Methicillin-resistant strains are often resistant to other classes of antibiotics, making their treatment difficult. Nigella sativa oil is known to be active against Gram-positive cocci, yet its in vitro cytotoxicity is rarely investigated, is a proper and powerful candidate for treatment of methicillin-resistant isolates. Objectives: The aim of this study is to evaluate the in vitro antibacterial activity and cytotoxicity effect of N. sativa oil. Materials and Methods: The minimal inhibitory concentrations (MICs) of N. sativa oil were determined by broth microdilution method against four different American Type Culture Collection strains, 45 clinical isolates of methicillin-resistant S. aureus (MRSA), and 77 methicillin-resistant CoNS (MRCoNS). The effects of different dilutions (0.25 mu g/mL, 0.5 mu g/mL, and 1 mu g/mL) of N. sativa oil on the proliferation of gingival fibroblasts were evaluated. Results: The MIC values of N. sativa oil against clinical isolates of Staphylococci were between < 0.25 mu g/mL and 1.0 mu g/mL. Compared to the control group, there was no cytotoxic effect on the proliferation of the gingival fibroblasts. Conclusion: In the present study, the oil of N. sativa was very active against MRSA and MRCoNS and had no in vitro cytotoxicity at relevant concentrations. These findings emphasize that there is a requirement for further clinical trials on N. sativa oil for "safe" medical management of infections caused by methicillin-resistant Staphylococci. | en_US |
dc.identifier.doi | 10.4103/0973-1296.191459 | en_US |
dc.identifier.endpage | S474 | en_US |
dc.identifier.issn | 0973-1296 | en_US |
dc.identifier.issn | 0976-4062 | en_US |
dc.identifier.issue | 47 | en_US |
dc.identifier.pmid | 27761077 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | S471 | en_US |
dc.identifier.uri | https://dx.doi.org/10.4103/0973-1296.191459 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/33283 | |
dc.identifier.volume | 12 | en_US |
dc.identifier.wos | WOS:000391129400014 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | MEDKNOW PUBLICATIONS & MEDIA PVT LTD | en_US |
dc.relation.ispartof | PHARMACOGNOSY MAGAZINE | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Cytotoxic effect | en_US |
dc.subject | methicillin-resistant Staphylococci | en_US |
dc.subject | microdilution | en_US |
dc.subject | Nigella sativa | en_US |
dc.title | Assessment of In vitro Antibacterial Activity and Cytotoxicity Effect of Nigella sativa Oil | en_US |
dc.type | Article | en_US |